Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids
Bo Zhang
European Journal of Medicinal Chemistry (2019) Vol. 168, pp. 357-372
Closed Access | Times Cited: 286

Showing 1-25 of 286 citing articles:

1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
Zhi Xu, Shijia Zhao, Yi Liu
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111700-111700
Closed Access | Times Cited: 425
Cu(I)-Catalyzed Click Chemistry in Glycoscience and Their Diverse Applications
Anand K. Agrahari, Priyanka Bose, Manoj K. Jaiswal, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 7638-7956
Closed Access | Times Cited: 314
Coumarin-containing hybrids and their anticancer activities
Longfei Zhang, Zhi Xu
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111587-111587
Closed Access | Times Cited: 202
Synthesis methods of 1,2,3-/1,2,4-triazoles: A review
Jinlian Dai, Sen Tian, Xueqing Yang, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 75
Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies
Manankar Koley, Jianlin Han, Vadim A. Soloshonok, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 10-54
Open Access | Times Cited: 43
1,2,3-triazole and chiral Schiff base hybrids as potential anticancer agents: DFT, molecular docking and ADME studies
Yonas Belay, Alfred Muller, Fanikie S. Mokoena, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Computational and electrochemistry of effective triazolyl-benzimidazolone inhibitors in aggressive environment
Rajae Salim, Mohamed Adardour, Walid Ettahiri, et al.
Sustainable materials and technologies (2024) Vol. 39, pp. e00862-e00862
Closed Access | Times Cited: 21
Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110099-110099
Closed Access | Times Cited: 16
1,2,3‐Triazole hybrids with anti‐HIV‐1 activity
Lian‐Shun Feng, Man‐Jie Zheng, Feng Zhao, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 1
Closed Access | Times Cited: 120
Coumarin‐containing hybrids and their antibacterial activities
Feng Dongxu, Aihua Zhang, Yuan Yang, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 6
Closed Access | Times Cited: 113
Current scenario of tetrazole hybrids for antibacterial activity
Feng Gao, Jiaqi Xiao, Gang Huang
European Journal of Medicinal Chemistry (2019) Vol. 184, pp. 111744-111744
Closed Access | Times Cited: 108
1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)
Zhi Xu
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112686-112686
Closed Access | Times Cited: 97
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies
Mohammad Asgari, Maryam Mohammadi‐Khanaposhtani, Mitra Kiani, et al.
Bioorganic Chemistry (2019) Vol. 92, pp. 103206-103206
Closed Access | Times Cited: 96
Recent accomplishments on the synthetic/biological facets of pharmacologically active 1H-1,2,3-triazoles
Sumit Kumar, Bharvi Sharma, Vishu Mehra, et al.
European Journal of Medicinal Chemistry (2020) Vol. 212, pp. 113069-113069
Closed Access | Times Cited: 93
1,2,3-Triazole-Containing Compounds as Anti–Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure–Activity Relationship
Ting Liang, Xiangyang Sun, Wenhong Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 93
A review on synthesis, mechanism of action, and structure-activity relationships of 1,2,3-triazole-based α-glucosidase inhibitors as promising anti-diabetic agents
Zari Fallah, Mahmood Tajbakhsh, Majid Alikhani, et al.
Journal of Molecular Structure (2022) Vol. 1255, pp. 132469-132469
Closed Access | Times Cited: 69
New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2
Israa A. Seliem, Siva S. Panda, Adel S. Girgis, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105117-105117
Open Access | Times Cited: 67
The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
Deniz Lengerli, Kübra İbiş, Yahya Nural, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 11, pp. 1209-1236
Closed Access | Times Cited: 56
Emerging impact of triazoles as anti-tubercular agent
Anindra Sharma, Anand K. Agrahari, Sanchayita Rajkhowa, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114454-114454
Closed Access | Times Cited: 54
The fate of heterogeneous catalysis & click chemistry for 1,2,3-triazoles: Nobel prize in chemistry 2022
Vijay Kumar, Kashmiri Lal, Naveen Naveen, et al.
Catalysis Communications (2023) Vol. 176, pp. 106629-106629
Open Access | Times Cited: 42
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
Hamada H. H. Mohammed, Amer Ali Abd El‐Hafeez, Kareem Ebeid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1346-1363
Open Access | Times Cited: 39
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
Maria Marinescu
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1220-1220
Open Access | Times Cited: 36
Synthesis of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazoles as potent EGFR targeting anti-breast cancer agents
Swathi Chirra, Ramesh Gondru, Manne Munikumar, et al.
Journal of Molecular Structure (2024) Vol. 1306, pp. 137803-137803
Closed Access | Times Cited: 11
Clicking in harmony: exploring the bio-orthogonal overlap in click chemistry
Mehak, Gurleen Singh, Riddima Singh, et al.
RSC Advances (2024) Vol. 14, Iss. 11, pp. 7383-7413
Open Access | Times Cited: 10
Discovery of novel thiazolidinone-1,2,3-triazole hybrids with (D)-Limonene skeleton as anticancer agents: Design, synthesis and biological evaluation
Yousef E. Mukhrish, Nasser Amri, Jehan Y. Al‐Humaidi, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138127-138127
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top